Moderna receives FDA approval for lower-dose COVID-19 vaccine, mNexspike, with restrictions on who can receive it.

Spun off from Novartis in 2019, Alcon is betting on new product launches to accelerate sales growth in the second half of ...

Stealth BioTherapeutics Inc. (the "Company" or "Stealth"), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving ...

(Reuters) - The U.S. Food and Drug Administration said on Wednesday it has approved the expanded use of Merck's cancer drug to treat two rare types of adrenal gland tumors. The drug, Welireg, became ...

As part of its attempt to force food companies to voluntarily stop using artificial food dyes, the FDA has approved three dyes that it says come from natural sources. Galdieria extract blue ...

Galdieria extract blue- It is a blue color derived from the unicellular red algae Galdieria sulphuraria, according to the FDA. It has been approved for use in nonalcoholic beverages and beverage ...

The FDA approved three natural food dyes this week amid its transition away from petroleum-based dyes in the food supply. The colors "will expand the palette of available colors from natural ...

RFK Jr. previously said he wants to phase out petroleum-based dyes. The U.S. Food and Drug Administration (FDA) approved on Friday additional color additives from natural sources in line with the ...

In the wake of mass restructuring efforts across the Department of Health and Human Services (HHS), the FDA has missed yet another approval decision target date. GSK had expected to secure an FDA ...

AVMAPKI FAKZYNJA CO-PACK is the first and only FDA-approved medicine for this disease. This indication is approved under accelerated approval based on the tumor response rate and duration of response.

The FDA approved Avmapki Fakzynja Co-pack for KRAS-mutated, recurrent, low-grade serous ovarian cancer after prior systemic therapy. The RAMP-201 trial showed a 44% response rate, with response ...